Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04570553 · ClinicalTrials.gov registry record · NA

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

A NA study of Endometrial Cancer, sponsored by WellSpan Health.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT04570553 is a NA study of Endometrial Cancer that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 350 participants, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04570553, a NA study of Endometrial Cancer, is actively recruiting participants, sponsored by WellSpan Health.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

Conditions Studied

Interventions

  • PROCEDURE surgical staging

Study Locations (1)

Pennsylvania

  • Wellspan Health - York

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2020-10-15
Est. Completion 2027-06-30
Phase NA

Sponsor

WellSpan Health

21 total trials

What the Registry Record Tells You About NCT04570553

The ClinicalTrials.gov registry entry for NCT04570553 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (33% lower). The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which surgical staging is the first listed.

NCT04570553 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04570553 about?

NCT04570553 is a clinical study titled "Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers". This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

What is the current status of trial NCT04570553?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2020-10-15. Estimated completion is 2027-06-30.

What conditions does trial NCT04570553 study?

This clinical trial studies the following conditions: Endometrial Cancer.

What interventions are being tested in trial NCT04570553?

The interventions under investigation include: surgical staging (PROCEDURE).

Who is sponsoring clinical trial NCT04570553?

This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04570553 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.